Pacific Symposium on Biocomputing (PSB)BioinformaticsPeer-reviewed journal article
AICM: A Genuine Framework for Correcting Inconsistency Between Large Pharmacogenomics Datasets
Zhiyue Tom HuiD, Yuting YeiD, Patrick A. NewburyiD, Haiyan HuangiD, Bin CheniD
Abstract
The inconsistency of open pharmacogenomics datasets produced by different studies limits the usage of pharmacogenomics in biomarker discovery. Investigation of multiple pharmacogenomics datasets confirmed that the pairwise sensitivity data correlation between drugs, or rows, across different studies (drug-wise) is relatively low, while the pairwise sensitivity data correlation between cell-lines, or columns, across different studies (cell-wise) is considerably strong. This common interesting observation across multiple pharmacogenomics datasets suggests the existence of subtle consistency among the different studies (i.e., strong cell-wise correlation). However, significant noises are also shown (i.e., weak drug-wise correlation) and have prevented researchers from comfortably using the data directly. Motivated by this observation, we propose a novel framework for addressing the inconsistency between large-scale pharmacogenomics data sets. Our method can significantly boost the drug-wise correlation and can be easily applied to re-summarized and normalized datasets proposed by others. We also investigate our algorithm based on many different criteria to demonstrate that the corrected datasets are not only consistent, but also biologically meaningful. Eventually, we propose to extend our main algorithm into a framework, so that in the future when more data-sets become publicly available, our framework can hopefully offer a \"ground-truth\" guidance for references.
- assay: GWAS summary statistics
- research focus: benchmarking
- research focus: variant effect prediction
- research focus: drug response / drug discovery
- research focus: perturbation response prediction
- approach: statistical model
- Citations
- 7
- FWCI
- 0.28
- Field percentile
- top 48%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Large-Scale Information Retrieval and Correction of Noisy Pharmacogenomic Datasets through Residual Thresholded Deep Matrix Factorization
Zhiyue Tom Hu, Yaodong Yu, … Haiyan Huang·Briefings in BioinformaticsPeer-reviewed·May 1, 2025
- Improving reproducibility in pharmacogenomic screens through cross-study benchmarking
Kristen Michelle Nader, Filipp Ianevski, … Tero A. Aittokallio·bioRxiv·May 3, 2026
- Revisiting inconsistency in large pharmacogenomic studies
Zhaleh Safikhani, Mark Freeman, … Benjamin Haibe-Kains·F1000ResearchPeer-reviewed·Aug 11, 2017
- Assessment of pharmacogenomic agreement
Zhaleh Safikhani, Nehme El-Hachem, … Benjamin Haibe-Kains·F1000ResearchPeer-reviewed·May 9, 2016
- PharmacoDB: an integrative database for mining in vitro anticancer drug screening studies
Petr Smirnov, Victor Kofia, … Benjamin Haibe‐Kains·Nucleic Acids ResearchPeer-reviewed·Sep 27, 2017
- PharmacoDB 2.0 : Improving scalability and transparency of in vitro pharmacogenomics analysis
Nikta Feizi, Sisira Kadambat Nair, … Benjamin Haibe‐Kains·Nucleic Acids ResearchPeer-reviewed·Oct 20, 2021